Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism (UDEM), Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Ann Nutr Metab. 2023;79(3):326-333. doi: 10.1159/000530082. Epub 2023 Mar 17.
Home parenteral nutrition (HPN) is a rare but challenging therapy for patients with mostly severe underlying diseases. We aimed to investigate patient-reported health-related quality of life (QOL) of patients receiving HPN and its development over time in particular.
We assessed QOL of HPN patients in a prospective multicenter observational study (SWISSHPN II study). We designed a questionnaire to record symptoms and negative impacts of HPN and completed the validated Optum® SF-36v2® Health Survey with the patients.
Seventy patients (50% women) on HPN were included. HPN commonly affected feelings of dependency (n = 49, 70%), traveling/leaving home (n = 37, 53%), attending cultural and social events (n = 25, 36%), and sleep (n = 22, 31%). Most frequently reported symptoms were diarrhea (n = 30, 43%), polyuria (n = 28, 40%), nausea/emesis (n = 27, 39%), dysgeusia (n = 23, 33%), and cramps (n = 20, 29%). At baseline, mean (standard deviation) SF-36v2® physical and mental health component summary scores (PCS and MCS) were 45 (20) and 57 (19), respectively, and there was a trend toward improvement in PCS over the study period, while MCS remained stable. Satisfaction with health care professionals involved in HPN care was high.
QOL is a crucial and decisive aspect of HPN patient care. Symptoms related to the underlying disease and PN are frequent. Impaired social life and an ambivalent attitude toward the life-saving therapy are major concerns for these patients and should be addressed in their care.
家庭肠外营养(HPN)是一种针对大多数严重基础疾病患者的罕见但具有挑战性的治疗方法。我们旨在研究接受 HPN 的患者的患者报告的健康相关生活质量(QOL)及其随时间的发展。
我们在一项前瞻性多中心观察性研究(SWISSHPN II 研究)中评估了 HPN 患者的 QOL。我们设计了一个问卷来记录 HPN 的症状和负面影响,并与患者一起完成了经过验证的 Optum® SF-36v2®健康调查。
70 名(50%女性)接受 HPN 的患者被纳入研究。HPN 通常会影响患者的依赖感(n = 49,70%)、旅行/离家(n = 37,53%)、参加文化和社会活动(n = 25,36%)和睡眠(n = 22,31%)。最常报告的症状是腹泻(n = 30,43%)、多尿(n = 28,40%)、恶心/呕吐(n = 27,39%)、味觉障碍(n = 23,33%)和抽筋(n = 20,29%)。基线时,SF-36v2® 生理和心理健康成分综合评分(PCS 和 MCS)的平均值(标准差)分别为 45(20)和 57(19),并且 PCS 在研究期间呈上升趋势,而 MCS 保持稳定。对参与 HPN 护理的医疗保健专业人员的满意度很高。
QOL 是 HPN 患者护理的一个关键和决定性方面。与基础疾病和 PN 相关的症状很常见。社会生活受损和对救命治疗的矛盾态度是这些患者的主要关注点,应在他们的护理中得到解决。